Arny Ferrando
Concepts (339)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscle Proteins | 47 | 2024 | 321 | 5.960 |
Why?
| Dietary Proteins | 22 | 2024 | 252 | 5.760 |
Why?
| Muscle, Skeletal | 52 | 2025 | 804 | 5.670 |
Why?
| Amino Acids, Essential | 26 | 2024 | 133 | 4.390 |
Why?
| Amino Acids | 19 | 2023 | 377 | 4.100 |
Why?
| Protein Biosynthesis | 12 | 2021 | 258 | 2.780 |
Why?
| Proteins | 9 | 2025 | 348 | 1.920 |
Why?
| Dietary Supplements | 17 | 2025 | 465 | 1.830 |
Why?
| Body Composition | 20 | 2023 | 338 | 1.820 |
Why?
| Meals | 7 | 2024 | 63 | 1.800 |
Why?
| Bed Rest | 9 | 2009 | 36 | 1.800 |
Why?
| Feeding Behavior | 4 | 2024 | 192 | 1.740 |
Why?
| Exercise | 21 | 2025 | 547 | 1.660 |
Why?
| Muscular Atrophy | 4 | 2021 | 71 | 1.640 |
Why?
| Military Personnel | 5 | 2023 | 177 | 1.420 |
Why?
| Aging | 10 | 2025 | 701 | 1.330 |
Why?
| Phenylalanine | 12 | 2022 | 132 | 1.320 |
Why?
| Dietary Carbohydrates | 7 | 2025 | 90 | 1.220 |
Why?
| Sarcopenia | 5 | 2025 | 98 | 1.210 |
Why?
| Anabolic Agents | 10 | 2025 | 44 | 1.190 |
Why?
| Quadriceps Muscle | 3 | 2023 | 47 | 1.080 |
Why?
| Isotopes | 3 | 2022 | 25 | 1.020 |
Why?
| Humans | 99 | 2025 | 52483 | 1.010 |
Why?
| Arthroplasty, Replacement, Hip | 4 | 2022 | 266 | 1.000 |
Why?
| Eating | 5 | 2022 | 159 | 1.000 |
Why?
| Energy Metabolism | 10 | 2025 | 302 | 0.980 |
Why?
| Kidney Failure, Chronic | 8 | 2010 | 210 | 0.960 |
Why?
| Muscle Strength | 8 | 2025 | 130 | 0.940 |
Why?
| Male | 67 | 2025 | 26761 | 0.930 |
Why?
| Renal Dialysis | 7 | 2010 | 179 | 0.850 |
Why?
| Hydrocortisone | 7 | 2012 | 111 | 0.850 |
Why?
| Stress, Physiological | 2 | 2019 | 183 | 0.820 |
Why?
| Testosterone | 7 | 2022 | 141 | 0.770 |
Why?
| Glucose | 4 | 2025 | 355 | 0.710 |
Why?
| Malnutrition | 2 | 2021 | 90 | 0.690 |
Why?
| Postoperative Care | 1 | 2021 | 104 | 0.690 |
Why?
| Aged | 26 | 2025 | 10121 | 0.690 |
Why?
| Muscle Contraction | 2 | 2019 | 117 | 0.680 |
Why?
| Female | 48 | 2025 | 28171 | 0.670 |
Why?
| Diet | 7 | 2024 | 587 | 0.660 |
Why?
| Preoperative Care | 1 | 2021 | 173 | 0.660 |
Why?
| Adult | 42 | 2025 | 14161 | 0.640 |
Why?
| Postprandial Period | 6 | 2021 | 73 | 0.640 |
Why?
| Military Medicine | 1 | 2019 | 24 | 0.630 |
Why?
| Proteome | 1 | 2020 | 171 | 0.620 |
Why?
| Burns | 7 | 2012 | 163 | 0.610 |
Why?
| Occupational Diseases | 1 | 2019 | 85 | 0.590 |
Why?
| Middle Aged | 29 | 2024 | 13028 | 0.580 |
Why?
| Breakfast | 1 | 2017 | 16 | 0.560 |
Why?
| Kinetics | 10 | 2025 | 626 | 0.550 |
Why?
| Nitrogen | 4 | 2022 | 70 | 0.540 |
Why?
| Insulin | 10 | 2021 | 479 | 0.530 |
Why?
| Hormones | 4 | 2019 | 59 | 0.510 |
Why?
| Muscular Diseases | 2 | 2006 | 63 | 0.480 |
Why?
| Cross-Over Studies | 8 | 2022 | 238 | 0.460 |
Why?
| Leucine | 6 | 2023 | 114 | 0.460 |
Why?
| Insulin Resistance | 2 | 2021 | 275 | 0.440 |
Why?
| Body Mass Index | 8 | 2021 | 689 | 0.430 |
Why?
| Liver Transplantation | 3 | 2020 | 165 | 0.420 |
Why?
| Absorptiometry, Photon | 5 | 2023 | 162 | 0.380 |
Why?
| Triglycerides | 2 | 2009 | 165 | 0.370 |
Why?
| Osteoarthritis | 2 | 2022 | 61 | 0.370 |
Why?
| Tyrosine | 3 | 2022 | 87 | 0.370 |
Why?
| Blood Glucose | 6 | 2025 | 473 | 0.370 |
Why?
| Nutritional Status | 3 | 2021 | 137 | 0.350 |
Why?
| Nutritional Requirements | 3 | 2022 | 67 | 0.350 |
Why?
| Cytokines | 6 | 2015 | 623 | 0.330 |
Why?
| Cushing Syndrome | 1 | 2009 | 9 | 0.330 |
Why?
| Resistance Training | 6 | 2025 | 101 | 0.330 |
Why?
| Homeostasis | 2 | 2014 | 201 | 0.320 |
Why?
| Caloric Restriction | 3 | 2025 | 38 | 0.310 |
Why?
| Myositis | 2 | 2022 | 20 | 0.310 |
Why?
| Immobilization | 2 | 2007 | 15 | 0.300 |
Why?
| End Stage Liver Disease | 2 | 2020 | 48 | 0.300 |
Why?
| Metabolism | 4 | 2020 | 25 | 0.300 |
Why?
| Nandrolone | 2 | 2025 | 6 | 0.300 |
Why?
| Alanine | 2 | 2025 | 44 | 0.290 |
Why?
| Isotope Labeling | 2 | 2019 | 57 | 0.290 |
Why?
| Nutritional Physiological Phenomena | 1 | 2008 | 22 | 0.290 |
Why?
| Energy Intake | 5 | 2024 | 174 | 0.280 |
Why?
| Muscle Fibers, Slow-Twitch | 1 | 2006 | 12 | 0.260 |
Why?
| Muscle Fibers, Fast-Twitch | 1 | 2006 | 14 | 0.260 |
Why?
| Food, Formulated | 3 | 2019 | 42 | 0.260 |
Why?
| Glucose Transport Proteins, Facilitative | 1 | 2006 | 9 | 0.260 |
Why?
| Young Adult | 13 | 2025 | 4329 | 0.260 |
Why?
| Double-Blind Method | 7 | 2021 | 713 | 0.260 |
Why?
| Liver Cirrhosis | 2 | 2020 | 240 | 0.260 |
Why?
| Biopsy, Needle | 2 | 2015 | 183 | 0.250 |
Why?
| Quality of Life | 5 | 2025 | 879 | 0.240 |
Why?
| Food | 2 | 2020 | 66 | 0.240 |
Why?
| Infusions, Intravenous | 2 | 2021 | 220 | 0.240 |
Why?
| Muscle Fatigue | 1 | 2025 | 15 | 0.240 |
Why?
| Ecchymosis | 1 | 2004 | 8 | 0.230 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2025 | 69 | 0.230 |
Why?
| Blood Specimen Collection | 1 | 2004 | 35 | 0.230 |
Why?
| Fatigue | 1 | 2025 | 125 | 0.230 |
Why?
| Hematoma | 1 | 2004 | 65 | 0.220 |
Why?
| Body Weight | 3 | 2018 | 523 | 0.220 |
Why?
| Catheterization | 1 | 2004 | 96 | 0.220 |
Why?
| Physical Endurance | 1 | 2024 | 34 | 0.220 |
Why?
| Fibrinogen | 1 | 2004 | 34 | 0.220 |
Why?
| Albumins | 1 | 2004 | 32 | 0.220 |
Why?
| Basal Metabolism | 2 | 2020 | 33 | 0.220 |
Why?
| Amino Acid Transport Systems | 1 | 2003 | 5 | 0.220 |
Why?
| Liver | 3 | 2024 | 1156 | 0.220 |
Why?
| Digestion | 2 | 2020 | 29 | 0.220 |
Why?
| Glutamic Acid | 1 | 2004 | 104 | 0.210 |
Why?
| Proteolysis | 2 | 2020 | 101 | 0.210 |
Why?
| Menopause | 1 | 2023 | 38 | 0.200 |
Why?
| Musculoskeletal Physiological Phenomena | 1 | 2002 | 7 | 0.200 |
Why?
| Weightlessness | 1 | 2002 | 13 | 0.200 |
Why?
| Obesity | 2 | 2021 | 1162 | 0.200 |
Why?
| Biological Availability | 2 | 2019 | 108 | 0.200 |
Why?
| Space Flight | 1 | 2002 | 32 | 0.200 |
Why?
| Urea | 1 | 2022 | 82 | 0.200 |
Why?
| Oxandrolone | 3 | 2011 | 10 | 0.190 |
Why?
| GTP-Binding Proteins | 1 | 2022 | 85 | 0.190 |
Why?
| Overweight | 2 | 2021 | 224 | 0.190 |
Why?
| Reindeer | 1 | 2021 | 3 | 0.190 |
Why?
| Egg Proteins | 2 | 2021 | 18 | 0.190 |
Why?
| Mice, Inbred C57BL | 2 | 2025 | 1884 | 0.190 |
Why?
| Exercise Therapy | 2 | 2020 | 100 | 0.190 |
Why?
| Sports | 1 | 2022 | 45 | 0.180 |
Why?
| Postoperative Complications | 2 | 2021 | 1068 | 0.180 |
Why?
| Food Analysis | 1 | 2021 | 28 | 0.180 |
Why?
| Models, Biological | 4 | 2007 | 735 | 0.180 |
Why?
| Actinidia | 1 | 2020 | 7 | 0.170 |
Why?
| Osteoarthritis, Knee | 1 | 2022 | 97 | 0.170 |
Why?
| Cross-Sectional Studies | 2 | 2023 | 1678 | 0.170 |
Why?
| Hyperphagia | 1 | 2020 | 9 | 0.170 |
Why?
| Orthopedic Procedures | 1 | 2021 | 71 | 0.170 |
Why?
| Hyperammonemia | 1 | 2020 | 24 | 0.170 |
Why?
| Hepatic Encephalopathy | 1 | 2020 | 29 | 0.170 |
Why?
| Mitochondria, Muscle | 1 | 2020 | 40 | 0.170 |
Why?
| Ketoconazole | 2 | 2012 | 10 | 0.170 |
Why?
| Fatty Acids, Omega-3 | 1 | 2020 | 29 | 0.170 |
Why?
| Mitochondrial Proteins | 1 | 2020 | 89 | 0.170 |
Why?
| Animals | 7 | 2025 | 13505 | 0.170 |
Why?
| Carbohydrate Metabolism | 1 | 2019 | 23 | 0.160 |
Why?
| Risk Assessment | 1 | 2004 | 1327 | 0.160 |
Why?
| Metabolomics | 1 | 2021 | 150 | 0.160 |
Why?
| Liver Diseases | 1 | 2020 | 83 | 0.160 |
Why?
| Whole Body Imaging | 1 | 2019 | 26 | 0.160 |
Why?
| Receptors, Tumor Necrosis Factor | 2 | 2018 | 39 | 0.150 |
Why?
| Occupational Health | 1 | 2019 | 66 | 0.150 |
Why?
| Autophagy | 1 | 2020 | 193 | 0.150 |
Why?
| Home Care Services | 1 | 2020 | 72 | 0.150 |
Why?
| Motor Activity | 3 | 2010 | 223 | 0.150 |
Why?
| Altitude Sickness | 1 | 2018 | 8 | 0.150 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2022 | 289 | 0.150 |
Why?
| Sex Factors | 1 | 2020 | 727 | 0.150 |
Why?
| Time Factors | 5 | 2021 | 2968 | 0.150 |
Why?
| Diet, High-Fat | 1 | 2020 | 236 | 0.150 |
Why?
| Inflammation | 3 | 2022 | 641 | 0.140 |
Why?
| Altitude | 1 | 2018 | 16 | 0.140 |
Why?
| Leg | 3 | 2011 | 120 | 0.140 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2004 | 560 | 0.140 |
Why?
| Waiting Lists | 1 | 2018 | 55 | 0.140 |
Why?
| Oxidation-Reduction | 3 | 2025 | 326 | 0.130 |
Why?
| Adolescent | 8 | 2024 | 6739 | 0.120 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 490 | 0.120 |
Why?
| Age Factors | 3 | 2014 | 1132 | 0.120 |
Why?
| Risk Factors | 2 | 2019 | 3889 | 0.120 |
Why?
| Oxidative Stress | 3 | 2025 | 807 | 0.120 |
Why?
| Beverages | 2 | 2019 | 57 | 0.120 |
Why?
| Osteoarthritis, Hip | 1 | 2015 | 28 | 0.120 |
Why?
| Insulin-Like Growth Factor I | 2 | 2007 | 139 | 0.110 |
Why?
| Gene Expression | 3 | 2006 | 618 | 0.110 |
Why?
| Heart Failure | 1 | 2019 | 565 | 0.100 |
Why?
| Glycogen | 2 | 2025 | 44 | 0.100 |
Why?
| Cattle | 2 | 2024 | 205 | 0.100 |
Why?
| Meat | 2 | 2024 | 60 | 0.100 |
Why?
| Caspase 3 | 2 | 2010 | 95 | 0.100 |
Why?
| Deuterium | 2 | 2025 | 46 | 0.100 |
Why?
| Weight Loss | 2 | 2018 | 248 | 0.100 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2025 | 399 | 0.100 |
Why?
| Biopsy | 5 | 2020 | 605 | 0.090 |
Why?
| Fasting | 2 | 2020 | 75 | 0.090 |
Why?
| Aged, 80 and over | 5 | 2021 | 3392 | 0.090 |
Why?
| Glucose Clamp Technique | 1 | 2009 | 15 | 0.080 |
Why?
| Glycerol | 1 | 2009 | 19 | 0.080 |
Why?
| Arginine | 2 | 2008 | 182 | 0.080 |
Why?
| Fatty Acids, Nonesterified | 1 | 2009 | 39 | 0.080 |
Why?
| Random Allocation | 2 | 2024 | 285 | 0.080 |
Why?
| Athletes | 2 | 2022 | 104 | 0.080 |
Why?
| Protein-Energy Malnutrition | 1 | 2009 | 19 | 0.080 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 134 | 0.080 |
Why?
| Exercise Test | 2 | 2020 | 141 | 0.080 |
Why?
| Linear Models | 1 | 2009 | 287 | 0.080 |
Why?
| Administration, Oral | 3 | 2009 | 451 | 0.080 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 17 | 0.080 |
Why?
| Milk Proteins | 1 | 2009 | 77 | 0.070 |
Why?
| Signal Transduction | 2 | 2020 | 1671 | 0.070 |
Why?
| Blotting, Western | 3 | 2010 | 590 | 0.070 |
Why?
| Analysis of Variance | 1 | 2009 | 554 | 0.070 |
Why?
| RNA, Messenger | 3 | 2006 | 1132 | 0.070 |
Why?
| Regional Blood Flow | 2 | 2009 | 109 | 0.070 |
Why?
| Human Growth Hormone | 1 | 2007 | 50 | 0.070 |
Why?
| Herpesvirus 4, Human | 1 | 2007 | 43 | 0.070 |
Why?
| Virus Activation | 1 | 2007 | 39 | 0.070 |
Why?
| Longitudinal Studies | 2 | 2025 | 747 | 0.070 |
Why?
| Biological Transport | 1 | 2007 | 160 | 0.070 |
Why?
| Glucose Transporter Type 3 | 1 | 2006 | 4 | 0.070 |
Why?
| Glucose Transporter Type 5 | 1 | 2006 | 5 | 0.070 |
Why?
| Glucose Transporter Type 4 | 1 | 2006 | 23 | 0.070 |
Why?
| Glucose Transporter Type 1 | 1 | 2006 | 17 | 0.070 |
Why?
| Amino Acids, Branched-Chain | 1 | 2007 | 43 | 0.060 |
Why?
| Ubiquitin | 2 | 2003 | 47 | 0.060 |
Why?
| Health | 1 | 2006 | 21 | 0.060 |
Why?
| Metabolic Diseases | 1 | 2006 | 46 | 0.060 |
Why?
| Rest | 1 | 2006 | 60 | 0.060 |
Why?
| Deuterium Oxide | 1 | 2025 | 10 | 0.060 |
Why?
| Sirolimus | 1 | 2025 | 65 | 0.060 |
Why?
| Physical Conditioning, Animal | 1 | 2025 | 59 | 0.060 |
Why?
| Texas | 1 | 2004 | 143 | 0.060 |
Why?
| Hospitalization | 1 | 2009 | 736 | 0.060 |
Why?
| Metformin | 1 | 2025 | 76 | 0.060 |
Why?
| Reference Values | 1 | 2004 | 313 | 0.060 |
Why?
| Mice | 2 | 2025 | 5949 | 0.050 |
Why?
| Veins | 1 | 2004 | 74 | 0.050 |
Why?
| Arteries | 1 | 2004 | 92 | 0.050 |
Why?
| Inulin | 1 | 2003 | 10 | 0.050 |
Why?
| Physical Fitness | 2 | 2018 | 57 | 0.050 |
Why?
| Critical Illness | 1 | 2006 | 317 | 0.050 |
Why?
| Androgens | 1 | 2024 | 70 | 0.050 |
Why?
| Immunohistochemistry | 1 | 2006 | 979 | 0.050 |
Why?
| Osmolar Concentration | 1 | 2003 | 62 | 0.050 |
Why?
| Electric Impedance | 1 | 2023 | 49 | 0.050 |
Why?
| Apoptosis | 2 | 2010 | 1119 | 0.050 |
Why?
| Treatment Outcome | 4 | 2011 | 5422 | 0.050 |
Why?
| Weightlessness Countermeasures | 1 | 2002 | 2 | 0.050 |
Why?
| Multienzyme Complexes | 1 | 2003 | 40 | 0.050 |
Why?
| Wounds and Injuries | 1 | 2006 | 309 | 0.050 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 67 | 0.050 |
Why?
| Comorbidity | 1 | 2004 | 625 | 0.050 |
Why?
| Carbohydrates | 1 | 2022 | 41 | 0.050 |
Why?
| Polyesters | 1 | 2022 | 14 | 0.050 |
Why?
| Diuresis | 1 | 2002 | 14 | 0.050 |
Why?
| Injections, Intramuscular | 1 | 2002 | 56 | 0.050 |
Why?
| Prognosis | 2 | 2020 | 2099 | 0.050 |
Why?
| Placebos | 1 | 2002 | 85 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 117 | 0.050 |
Why?
| Receptors, Androgen | 1 | 2002 | 46 | 0.050 |
Why?
| History, 20th Century | 1 | 2022 | 96 | 0.050 |
Why?
| Muscles | 1 | 2022 | 107 | 0.050 |
Why?
| Arkansas | 2 | 2020 | 2028 | 0.050 |
Why?
| Prostate | 1 | 2002 | 116 | 0.050 |
Why?
| Incidence | 1 | 2004 | 1062 | 0.050 |
Why?
| Reproducibility of Results | 1 | 2025 | 1229 | 0.050 |
Why?
| Knee Joint | 1 | 2022 | 165 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 196 | 0.050 |
Why?
| Myocardium | 1 | 2024 | 453 | 0.040 |
Why?
| Urine | 1 | 2021 | 25 | 0.040 |
Why?
| Neoplasms | 1 | 2011 | 1325 | 0.040 |
Why?
| Food, Fortified | 1 | 2021 | 27 | 0.040 |
Why?
| Endothelial Cells | 1 | 2022 | 262 | 0.040 |
Why?
| Plant Proteins | 1 | 2021 | 71 | 0.040 |
Why?
| Mitochondrial Dynamics | 1 | 2020 | 23 | 0.040 |
Why?
| Prospective Studies | 2 | 2020 | 2481 | 0.040 |
Why?
| Geriatric Assessment | 1 | 2021 | 117 | 0.040 |
Why?
| Ceramides | 1 | 2020 | 34 | 0.040 |
Why?
| Phospholipids | 1 | 2020 | 59 | 0.040 |
Why?
| Algorithms | 1 | 2004 | 672 | 0.040 |
Why?
| Protein Kinases | 1 | 2020 | 72 | 0.040 |
Why?
| Metabolic Clearance Rate | 1 | 2019 | 69 | 0.040 |
Why?
| Respiratory Function Tests | 1 | 2020 | 90 | 0.040 |
Why?
| Statistics, Nonparametric | 2 | 2011 | 192 | 0.040 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 169 | 0.040 |
Why?
| Anthropometry | 1 | 2020 | 101 | 0.040 |
Why?
| Fruit | 1 | 2020 | 128 | 0.040 |
Why?
| Lipid Metabolism | 1 | 2020 | 187 | 0.040 |
Why?
| Molecular Probe Techniques | 1 | 2019 | 9 | 0.040 |
Why?
| Evaluation Studies as Topic | 1 | 2019 | 105 | 0.040 |
Why?
| Child | 5 | 2012 | 7248 | 0.040 |
Why?
| Intestinal Absorption | 1 | 2019 | 46 | 0.040 |
Why?
| Kidney | 1 | 2024 | 707 | 0.040 |
Why?
| Ileum | 1 | 2019 | 88 | 0.040 |
Why?
| Oxygen Consumption | 1 | 2019 | 198 | 0.040 |
Why?
| Rats | 1 | 2025 | 3220 | 0.040 |
Why?
| Acute Disease | 1 | 2019 | 373 | 0.040 |
Why?
| Myogenin | 1 | 2018 | 4 | 0.040 |
Why?
| PAX7 Transcription Factor | 1 | 2018 | 10 | 0.040 |
Why?
| Glucose Intolerance | 2 | 2008 | 27 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2003 | 1105 | 0.040 |
Why?
| Lower Extremity | 2 | 2009 | 100 | 0.040 |
Why?
| Pilot Projects | 1 | 2020 | 721 | 0.030 |
Why?
| Severity of Illness Index | 1 | 2020 | 1026 | 0.030 |
Why?
| Athletic Performance | 1 | 2017 | 33 | 0.030 |
Why?
| Interleukin-6 | 2 | 2010 | 278 | 0.030 |
Why?
| Outpatient Clinics, Hospital | 1 | 2015 | 35 | 0.030 |
Why?
| Hospitals, University | 1 | 2015 | 75 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2015 | 95 | 0.030 |
Why?
| Early Diagnosis | 1 | 2015 | 95 | 0.030 |
Why?
| Creatine | 1 | 2014 | 39 | 0.030 |
Why?
| Caffeine | 1 | 2014 | 61 | 0.030 |
Why?
| Reoperation | 1 | 2015 | 465 | 0.020 |
Why?
| 14-alpha Demethylase Inhibitors | 1 | 2012 | 2 | 0.020 |
Why?
| Gene Expression Regulation | 2 | 2010 | 990 | 0.020 |
Why?
| Acute-Phase Proteins | 1 | 2012 | 24 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2015 | 944 | 0.020 |
Why?
| Adipose Tissue | 1 | 2014 | 204 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2003 | 405 | 0.020 |
Why?
| United States | 1 | 2021 | 5192 | 0.020 |
Why?
| Amino-Acid N-Acetyltransferase | 1 | 2010 | 2 | 0.020 |
Why?
| Protein Modification, Translational | 1 | 2009 | 3 | 0.020 |
Why?
| Antifungal Agents | 1 | 2012 | 347 | 0.020 |
Why?
| Hypertrophy | 1 | 2009 | 52 | 0.020 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 3 | 0.020 |
Why?
| Down-Regulation | 1 | 2010 | 346 | 0.020 |
Why?
| Muscle Strength Dynamometer | 1 | 2008 | 12 | 0.020 |
Why?
| Movement | 1 | 2008 | 82 | 0.020 |
Why?
| Cholesterol | 1 | 2008 | 153 | 0.020 |
Why?
| Space Simulation | 1 | 2007 | 2 | 0.020 |
Why?
| Saliva | 1 | 2007 | 56 | 0.020 |
Why?
| Gait | 1 | 2008 | 88 | 0.020 |
Why?
| Case-Control Studies | 1 | 2010 | 1201 | 0.020 |
Why?
| Virus Latency | 1 | 2007 | 53 | 0.020 |
Why?
| Aerobiosis | 1 | 2006 | 13 | 0.020 |
Why?
| Actins | 1 | 2006 | 115 | 0.020 |
Why?
| Anti-Inflammatory Agents | 1 | 2007 | 166 | 0.020 |
Why?
| Hypertension, Renal | 1 | 2005 | 21 | 0.020 |
Why?
| Malondialdehyde | 1 | 2005 | 54 | 0.020 |
Why?
| Peptide Fragments | 1 | 2006 | 203 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2011 | 2279 | 0.020 |
Why?
| Interleukin-10 | 1 | 2005 | 84 | 0.020 |
Why?
| Interleukin-1 | 1 | 2005 | 107 | 0.020 |
Why?
| Blood Proteins | 1 | 2005 | 85 | 0.010 |
Why?
| Stress, Psychological | 1 | 2007 | 273 | 0.010 |
Why?
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2003 | 2 | 0.010 |
Why?
| Diet, Protein-Restricted | 1 | 2003 | 9 | 0.010 |
Why?
| Complement System Proteins | 1 | 2003 | 32 | 0.010 |
Why?
| Acidosis | 1 | 2003 | 41 | 0.010 |
Why?
| Food Additives | 1 | 2003 | 7 | 0.010 |
Why?
| Protein Array Analysis | 1 | 2003 | 24 | 0.010 |
Why?
| Organic Chemicals | 1 | 2003 | 15 | 0.010 |
Why?
| Caspases | 1 | 2003 | 104 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 2003 | 639 | 0.010 |
Why?
| Retrospective Studies | 1 | 2011 | 6607 | 0.010 |
Why?
| Child, Preschool | 1 | 2003 | 4076 | 0.010 |
Why?
|
|
Ferrando's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|